CN1229121C - Ointment for moistening burn and scald and its making method - Google Patents
Ointment for moistening burn and scald and its making method Download PDFInfo
- Publication number
- CN1229121C CN1229121C CN 02104031 CN02104031A CN1229121C CN 1229121 C CN1229121 C CN 1229121C CN 02104031 CN02104031 CN 02104031 CN 02104031 A CN02104031 A CN 02104031A CN 1229121 C CN1229121 C CN 1229121C
- Authority
- CN
- China
- Prior art keywords
- scald
- ointment
- burn
- propolis
- salve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to an ointment for moistening burns and scalds and a manufacturing method thereof. In the existing treatment for burns and scalds, because burns and scalds are easy to affect after bandaging, and patients have strong pain feel, the existing treatment only can carry out opening treatment. Besides, the existing treatment must have an asepsis sickroom. Therefore, the patients are not convenient to move. The product is composed of propolis, beeswax, vermilion, pearl, dahurian angelica, rhubarb and bean oil, and is used for traumatic patients who need to bandage and treat burns, sclads, electrical injury, chemical agent injury, etc.
Description
Technical field:
The present invention relates to a kind of moistness burn and scald Chinese medicine externally-applied ointment that is used in empyrosis wound surface.
Background technology:
There is not skin owing to wound surface in existing burn, the treatment of scald, contact the back once the very pain that just rubs takes place in motion with gauze or dressing, so generally adopt open treatment, but carry out the sterilizing room that open treatment needs strict sterilization, this for live in basic unit particularly the poor colony of economic condition be very the difficulty, particularly want strict restraint in the sterilizing room, cause the useless property used deformity easily.
Summary of the invention:
The present invention is to provide a kind of moistness ointment of the empyrosis that can the wrapping state uses down and the manufacture method of this ointment thereof.
Product of the present invention is by Vermilion 5-10: Margarita 5-15: Radix Angelicae Dahuricae 3-10: Radix Et Rhizoma Rhei 3-10: propolis 5-15: Cera Flava 30-80: Oleum Glycines 400-1000 forms.
The weight proportion of described Chinese medicine can also be Vermilion 10: Margarita 15: the Radix Angelicae Dahuricae 10: Radix Et Rhizoma Rhei 10: propolis 10: Cera Flava 50: Oleum Glycines 500.
The manufacture method of this moist salve for treating burn and scald:
A, above-mentioned solid Chinese medicine is made microgranule or nanometer grade powder;
B, the Chinese medicine solid is allocated in the described Oleum Glycines in above-mentioned ratio;
C, slow fire are heated to non-foam, add the propolis Cera Flava;
D, be boiled into paste after, filter and remove residue.
The invention has the advantages that:
1, in the medicine of the application's salve for treating burn and scald preparation, adopt the Chinese herbal medicine and the bee product of pure natural, playing synergistic function as the Radix Et Rhizoma Rhei in the medicine, propolis and other products after compound becomes a kind of well clear inflammation, antimicrobial drug.Radix Et Rhizoma Rhei, propolis, Vermilion, after adding compatibility antibacterial and anti-inflammation functions is arranged, through clinical trial, this product is to gram negative bacteria, staphylococcus aureus, escherichia coli, Bacillus proteus, aerobacteria, reach the susceptible antibacterials of burn and scald such as bacillus cloacae, very strong inhibition killing action is arranged.This ointment has anti-inflammatory analgetic, recover granulation promoting, impel slough to come off, accelerate the healing of empyrosis wound surface, the burn and scald of human body is had good therapeutical effect, clinical trial proves: this product is the activate immunity function effectively, the enhancing body energy, improve human body immunocompetence and resistance against diseases, blood circulation promoting, characteristics such as the back no cicatrix of erosion prevention and muscle growing.
2, this product curative effect is fast, and pain relieving rapidly is antipruritic in the energy short time, and it is strong to recover the granulation promoting ability, no pain, antisepsis in the therapeutic process, no scar after healing.Because wound surface does not have skin, the special pain of wrapping back friction, and be easy to infect used this product to alleviate friction and pain by mastic, and wound surface is packed easily, and has increased patient's ability to act greatly when at present general medicine used.Owing to do not need aseptic therapeutic room, the treatment cost is low, is fit to very much remote regional crowd such as rural area, forest zone and uses.
3, applied range goes for burn, scald, electric burn, chemicals burn etc.
4, use this salve for treating burn and scald in 53 routine patient's treatment clinical courses in recent years, cure rate has reached absolutely.With this Ointment in Treatment have no side effect, the no pain sense, have more characteristics such as the no cicatrix in back, anti-inflammatory analgetic, granulation promoting be fast.Wherein 1 spends burn and scald patient 28 examples, slight 17 examples, and wound surface is between 5~10%, recovered complete in 4-7 days with this ointment treatment, wound surface does not have cicatrix, severe burn and scald patient 11 examples, wound surface is between 5~15%, and the complete healing time of wound face 5~10 days is among the 2 degree burn and scald patients, wherein: shallow 2 degree burn and scald patients, 16 examples, wound surface is between 5~20%, behind this ointment, 10~20 days are complete, deep burn patient 9 examples, and wound surface is between 5~20%, behind this ointment, healed entirely in 10-20 days.Deep burn patient 9 examples, wound surface healed between 5~20% in 20-25 days entirely, more the no cicatrix in back.
In therapeutic process, because the human body immunocompetence is to the difference of medicine absorbability, also each is variant for healing time, by clinical use, the therapeutic effect of this ointment shows: curative effect is fast, with this ointment (about 10 minutes) different according to wound surface depth of burn and degree at short notice, can both play rapid pain relieving, antipruritic.This product also has having no side effect, recover fast, granulation promoting is fast, characteristics such as the no cicatrix in back heal, through 53 examples are burnt in various degree, patient's clinical treatment shows, reflect effectively, the patient can recover normal life, study and work at short notice, alleviates the burden to society and family, this salve for treating burn and scald is in the actual life really, a kind of ideal good medicine that the patient is in time taked.
5, processing technology is simple, and cost of manufacture is low, and manufactured goods are easy to keeping.
The specific embodiment:
Embodiment 1:
Moisten salve for treating burn and scald, by propolis, Cera Flava, Oleum Glycines, Vermilion, Margarita, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei and Oleum Glycines are formed, and its weight proportion is: Vermilion 5-10: Margarita 5-15: Radix Angelicae Dahuricae 3-10: Radix Et Rhizoma Rhei 3-10: propolis 5-15: Cera Flava 30-80: Oleum Glycines 400-1000.
The burn and scald face should be cleaned and sterilization with normal saline during use, clean decontamination, blister on the wound surface is punctured, draw sepage, remove foreign body and downright bad epithelium, reuse normal saline cleaning and sterilizing breaks into laminarly then with absorbent cotton, ointment is put on (1-2 millimeter) on the absorbent cotton deeply, be used for wound surface outward, bandage in order to avoid ointment is excessive, also can ointment directly be applied in the affected part according to wound surface degree size, then with the generation wrapping of stretching tight, change dressings every day once, heavily suffered from one day twice, the ointment and the residue that will remain in when changing dressings on the wound surface clean up.
Embodiment 2:
Above-mentioned moist salve for treating burn and scald, when the weight proportion of Chinese medicine is: Vermilion 10: Margarita 15: the Radix Angelicae Dahuricae 10: Radix Et Rhizoma Rhei 10: propolis 10: Cera Flava 50: effect is better during Oleum Glycines 500.
Embodiment 3:
A kind of manufacture method of moist salve for treating burn and scald:
A, above-mentioned solid Chinese medicine is made microgranule or nanometer grade powder;
B, the Chinese medicine solid is allocated in the described Oleum Glycines in above-mentioned ratio;
C, slow fire are heated to non-foam, add the propolis Cera Flava;
D, be boiled into paste after, filter and remove residue.
Claims (3)
1, a kind of moist salve for treating burn and scald is characterized in that: described ointment is by Vermilion 5-10: Margarita 5-15: Radix Angelicae Dahuricae 3-10: Radix Et Rhizoma Rhei 3-10: propolis 5-15: Cera Flava 30-80: Oleum Glycines 400-1000 makes.
2, moist salve for treating burn and scald according to claim 1, it is characterized in that: the weight proportion of described Chinese medicine is: Vermilion 10: Margarita 15: the Radix Angelicae Dahuricae 10: Radix Et Rhizoma Rhei 10: propolis 10: Cera Flava 50: Oleum Glycines 500.
3, the manufacture method of a kind of claim 1 or 2 described moist salve for treating burn and scald is characterized in that:
A, above-mentioned solid Chinese medicine is made microgranule or nanometer grade powder;
B, the Chinese medicine solid is allocated in the described Oleum Glycines in above-mentioned ratio;
C, slow fire are heated to non-foam, add the propolis Cera Flava;
D, be boiled into paste after, filter and remove residue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02104031 CN1229121C (en) | 2002-03-06 | 2002-03-06 | Ointment for moistening burn and scald and its making method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02104031 CN1229121C (en) | 2002-03-06 | 2002-03-06 | Ointment for moistening burn and scald and its making method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1442153A CN1442153A (en) | 2003-09-17 |
CN1229121C true CN1229121C (en) | 2005-11-30 |
Family
ID=27793036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02104031 Expired - Fee Related CN1229121C (en) | 2002-03-06 | 2002-03-06 | Ointment for moistening burn and scald and its making method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1229121C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102406727B (en) * | 2011-09-28 | 2013-10-23 | 鲁春燕 | Externally applied traditional Chinese medicine ointment for treating burns and scalds |
CN105769925A (en) * | 2016-05-01 | 2016-07-20 | 长葛市怡盛蜂业有限公司 | Honey and propolis physiotherapy patch |
-
2002
- 2002-03-06 CN CN 02104031 patent/CN1229121C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1442153A (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Simon et al. | Medical honey for wound care—still the ‘latest resort’? | |
CA2627214C (en) | Topical pharmaceutical compositions comprising amino acids and sodium hyaluronate | |
CN105142728B (en) | Compositions and methods for treating surface wounds | |
CN101310748B (en) | Ointment for treating empyrosis | |
US20140044667A1 (en) | Healing composition for topical application | |
Mashhood et al. | Honey compared with 1% silver sulfadiazine cream in the treatment of superficial and partial thickness burns | |
GB2391809A (en) | Pharmaceutical composition comprising honey | |
CN101569696A (en) | Chinese medicament for traumatic wound | |
CA2627223C (en) | Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate | |
WO2020144564A1 (en) | Composition for the treatment of skin lesions and irritations | |
CN1265822C (en) | Medicine for treating superficial and deep burn and scald | |
CN1229121C (en) | Ointment for moistening burn and scald and its making method | |
CN1053824C (en) | Exterior-use traditional Chinese medicine ointment and its preparing method | |
CN101401890B (en) | External use medicament capable of effectively treating wound surface infection | |
CN1176709C (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
Prasetyo et al. | The application of moist exposed burn ointment (MEBO) and binahong leaves in treating partial thickness burn: A case report | |
RU2177314C2 (en) | Composition eliciting antiseptic, reparative and analgetic properties | |
CN1116048C (en) | External-use extract for treating burns and scalds fast and its preparation | |
Galea et al. | Management of burn patients with Technology Lipido-Colloid with silver sulphate to fight local infection and restore the healing process | |
CN111939181A (en) | Medicinal powder for treating burns and scalds | |
Mahmood et al. | Evaluation of in vivo wound healing activity of Chromolaena odorata leaf extract on excision wounds model in rats | |
CN1258367C (en) | Medicine for treating trauma | |
CN101274047B (en) | External-use ointment for treating burn and method of preparing the same | |
CN105055713A (en) | Drug composition for preventing or curing bedsore and preparation method thereof | |
CN110859902A (en) | Medicine for treating burn, scald and trauma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051130 Termination date: 20140306 |